BLRX
BioLineRx Ltd
NASDAQ: BLRX · HEALTHCARE · BIOTECHNOLOGY
$2.79
-9.12% today
Updated 2026-04-30
Market cap
$10.21M
P/E ratio
0.00
P/S ratio
8.66x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$2 – $8
Volume
0.0M
BioLineRx Ltd (BLRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-27.96M | $-21.51M | $11.46M | $-11.22M | $-20.11M | $-20.23M | $-14.48M | $-14.17M | $-14.51M | $-20.55M | $-24.19M | $-22.67M | $-23.21M | $-23.57M | $-26.24M | $-22.61M | $-43.87M | $-8.14M |
| Capital expenditures | $908626.00 | $59830.00 | $660937.00 | $284813.00 | $176394.00 | $117157.00 | $178482.00 | $2.72M | $55000.00 | $4.24M | $10.22M | $73000.00 | $97000.00 | $97000.00 | $316000.00 | $297000.00 | $54000.00 | $25200.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $1.85M | $1.05M | $839949.00 | $872936.00 | $968687.00 | $1.15M | $1.07M | $1.51M | $2.53M | $1.76M | $1.27M | $1.50M | $2.25M | $2.32M | $1.14M | $396000.00 |
| Free cash flow | $-28.86M | $-21.57M | $10.80M | $-11.51M | $-20.29M | $-20.35M | $-14.66M | $-16.89M | $-14.57M | $-24.79M | $-34.41M | $-22.74M | $-23.30M | $-23.67M | $-26.56M | $-22.91M | $-43.93M | $-8.16M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |